Please use this identifier to cite or link to this item: http://lib.jncasr.ac.in:8080/jspui/handle/10572/2199
Title: Natural Tripeptide-Based Inhibitor of Multifaceted Amyloid beta Toxicity
Authors: Rajasekhar, K.
Madhu, Chilakapati
Govindaraju, T.
Keywords: Biochemistry & Molecular Biology
Pharmacology & Pharmacy
Neurosciences & Neurology
Alzheimer's disease
amyloid beta
multifunctional inhibitor
membrane disruption
DNA damage
oxidative stress
Alzheimers-Disease
A-Beta
Neurodegenerative Diseases
Peptide Aggregation
Hydrogen-Peroxide
Fibril Formation
Sheet Breaker
Copper
Oligomers
Complex
Issue Date: 2016
Publisher: American Chemical Society
Citation: Rajasekhar, K.; Madhu, C.; Govindaraju, T., Natural Tripeptide-Based Inhibitor of Multifaceted Amyloid beta Toxicity. Acs Chemical Neuroscience 2016, 7 (9), 1300-+ http://dx.doi.org/10.1021/acschemneuro.6600175
ACS Chemical Neuroscience
7
9
Abstract: Accumulation of amyloid beta (A beta) peptide and its aggregates in the human brain is considered as one of the hallmarks of Alzheimer's disease (AD). The polymorphic oligomers and fully grown fibrilar aggregates of A beta exhibit different levels of neuronal toxicity. Moreover, aggregation of A beta in the presence of redox-active metal ions like Cu2+ is responsible for the additional trait of cellular toxicity induced by the generation of reactive oxygen species (ROS). Herein, a multifunctional peptidomimetic inhibitor (P6) has been presented, based on a naturally occurring metal chelating tripeptide (GHK) and the inhibitor of A beta aggregation. It was shown by employing various biophysical studies that P6 interact with A beta and prevent the formation of toxic A beta forms like oligomeric species and fibrillar aggregates. Further, P6 successfully sequestered Cu2+ from the A beta-Cu2+ complex and maintained it in a redox-dormant state to prevent the generation of ROS. P6 inhibited membrane disruption by A beta oligomers and efficiently prevented DNA damage caused by the A beta-Cu2+ complex. PC12 cells were rescued from multifaceted A beta toxicity when treated with P6, and the amount of ROS generated in cells was reduced. These attributes make P6 a potential therapeutic candidate to ameliorate the multifaceted A toxicity in AD.
Description: Restricted Access
URI: http://hdl.handle.net/10572/2199
ISSN: 1948-7193
Appears in Collections:Research Papers (Govindaraju, T.)

Files in This Item:
File Description SizeFormat 
189.pdf
  Restricted Access
3.62 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.